Side-by-side comparison of AI visibility scores, market position, and capabilities
Paris France embedded analytics platform; raised €20M+; builds data story applications embedded inside business software for non-technical end users.
Toucan Toco is an embedded analytics platform founded in 2014 and headquartered in Paris, France. The company was founded by Charles Miglietti and Matthieu Beucher to help organizations embed data storytelling experiences inside their business applications, client portals, and digital products. Toucan Toco's design philosophy centers on making data understandable to non-technical end users through guided, narrative-style data presentations — "data stories" — rather than raw dashboards that require users to know what to look for and how to interpret metrics.\n\nToucan Toco raised over €20 million in funding from investors including Partech, Bpifrance, and XAnge. Its platform provides a white-label embedded analytics layer that ISVs, SaaS companies, and enterprises can integrate into their own products with full branding and customization. Toucan's no-code story builder allows non-technical teams to create interactive data stories by connecting to data sources, defining charts and KPIs, and adding narrative annotations and context — producing analytics applications that guide users through the data rather than leaving them to explore raw numbers. The platform is optimized for mobile and tablet consumption, recognizing that many business users interact with analytics on mobile devices.\n\nToucan Toco's embedded analytics positioning targets SaaS vendors that want to add analytics value to their product without building a BI engine from scratch, and enterprises that want to deliver data experiences to external customers or field teams who are not data professionals. The company's French roots, GDPR-compliant architecture, and European customer base make it a leading embedded analytics vendor in the European market alongside global competitors like Sigma Computing and Qlik.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.